Conflicting priorities in surgical intervention for cancer in pregnancy.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 17540305)

Published in Lancet Oncol on June 01, 2007

Authors

Brendan J Moran1, Hideaki Yano, Niall Al Zahir, Margaret Farquharson

Author Affiliations

1: Colorectal Research Unit, North Hampshire Hospital, Basingstoke, Hampshire, UK. Moran@bnhft.nhs.uk

Articles by these authors

State-dependent conformations of the translocation pathway in the tyrosine transporter Tyt1, a novel neurotransmitter:sodium symporter from Fusobacterium nucleatum. J Biol Chem (2006) 2.01

Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. J Biol Chem (2009) 1.55

CODA-RET reveals functional selectivity as a result of GPCR heteromerization. Nat Chem Biol (2011) 1.27

Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis. Gastroenterology (2011) 1.00

Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis. J Gastroenterol (2013) 0.89

Increase in colonic diverticulosis and diverticular hemorrhage in an aging society: lessons from a 9-year colonoscopic study of 28,192 patients in Japan. Int J Colorectal Dis (2013) 0.84

Lipopolysaccharide induces CD25-positive, IL-10-producing lymphocytes without secretion of proinflammatory cytokines in the human colon: low MD-2 mRNA expression in colonic macrophages. J Clin Immunol (2004) 0.80

Lateral pelvic lymph-node dissection: still an option for cure. Lancet Oncol (2010) 0.80

Endoscopic submucosal dissection of multiple flat adenomas in the radiated rectum. World J Gastrointest Endosc (2013) 0.78

Prognostic significance of 18q loss of heterzygosity in microsatellite-stable colorectal cancer. J Clin Oncol (2010) 0.76

A case of ileocecal actinomycosis treated by preoperative antibiotic treatment to reduce mass size followed by surgical resection. Nihon Shokakibyo Gakkai Zasshi (2016) 0.75

Synthesis and biological evaluation of a novel series of heterobivalent muscarinic ligands based on xanomeline and 1-[3-(4-butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1). J Med Chem (2014) 0.75